Frontiers in Oncology | Pediatric Oncology

Case Report

Published on 23 Mar 2023

Case report: First report of isolated central nervous system lymphoblastic crisis in a child with chronic myeloid leukemia on dasatinib therapy

in Pediatric Oncology

Suejung Jo
Jae Won Yoo
Seongkoo Kim
Jae Wook Lee
Soo-Ah Im
Bin Cho
Nack-Gyun Chung

Frontiers in Oncology

doi 10.3389/fonc.2023.1122714

2,323 views
4 citations

Original Research

Published on 21 Mar 2023

Integrated nontargeted and targeted metabolomics analyses amino acids metabolism in infantile hemangioma

in Pediatric Oncology

Kaiying Yang
Tong Qiu
Xue Gong
Jiangyuan Zhou
Yuru Lan
Siyuan Chen
Yi Ji

Frontiers in Oncology

doi 10.3389/fonc.2023.1132344

4,298 views
5 citations

Original Research

Published on 16 Mar 2023

Exploiting embryonic niche conditions to grow Wilms tumor blastema in culture

in Pediatric Oncology

Heather M. Wojcik
Harold N. Lovvorn
Melinda Hollingshead
Janene Pierce
Howard Stotler
Andrew J. Murphy
Suzanne Borgel
Hannah M. Phelps
Hernan Correa
Alan O. Perantoni

Frontiers in Oncology

doi 10.3389/fonc.2023.1091274

4,705 views
1 citation

Original Research

Published on 03 Mar 2023

In vivo loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymoma

in Pediatric Oncology

Jacqueline P. Whitehouse
Hilary Hii
Chelsea Mayoh
Marie Wong
Pamela Ajuyah
Paulette Barahona
Louise Cui
Hetal Dholaria
Christine L. White
Molly K. Buntine

Frontiers in Oncology

doi 10.3389/fonc.2023.1123492

4,970 views
5 citations

Original Research

Published on 02 Mar 2023

Transarterial arterial sclerosing embolization for the treatment of propranolol-resistant subglottic hemangioma: Feasibility and effificacy

in Pediatric Oncology

Zhuang Liu
Dan Song
Liang Wang
Jie Zhou
Changfeng Wang
Jing Li
Jiali Sun
Xian Zhang
Lei Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1062510

2,508 views
5 citations

Case Report

Published on 23 Feb 2023

Case report: Complete and durable response to larotrectinib (TRK inhibitor) in an infant diagnosed with angiosarcoma harbouring a KHDRBS1-NTRK3 fusion gene

in Pediatric Oncology

Catherine Cervi
Zoltán Sápi
Gábor Bedics
Erik Zajta
Lajos Hegyi
Judit Pápay
Katalin Dezső
Edit Varga
Katalin Mudra
Csaba Bödör

Frontiers in Oncology

doi 10.3389/fonc.2023.999810

3,575 views
5 citations

Correction

Published on 23 Feb 2023

Corrigendum: Murine models of acute myeloid leukemia

in Pediatric Oncology

Kristen J. Kurtz
Shannon E. Conneely
Madeleine O’Keefe
Katharina Wohlan
Rachel E. Rau

Frontiers in Oncology

doi 10.3389/fonc.2022.1089874

2,944 views
1 citation

Editorial

Published on 22 Feb 2023

Editorial: Critical complications in pediatric oncology and hematopoietic cell transplant – how far we have come and how much further we must go

in Pediatric Oncology

Asya Agulnik
Kris M. Mahadeo
Marie E. Steiner
Jennifer Ann McArthur

Frontiers in Oncology

doi 10.3389/fonc.2023.1148321

2,931 views
4 citations

Original Research

Published on 21 Feb 2023

Haploidentical hematopoietic stem cell transplantation as individual treatment option in pediatric patients with very high-risk sarcomas

in Pediatric Oncology

Thomas Eichholz
Michaela Döring
Stefano Giardino
Bernd Gruhn
Christian Seitz
Tim Flaadt
Wolfgang Schwinger
Martin Ebinger
Ursula Holzer
Markus Mezger

Frontiers in Oncology

doi 10.3389/fonc.2023.1064190

3,719 views
4 citations

Original Research

Published on 21 Feb 2023

MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma

in Pediatric Oncology

Thomas F. Eleveld
Lindy Vernooij
Linda Schild
Bianca Koopmans
Lindy K. Alles
Marli E. Ebus
Rana Dandis
Harm van Tinteren
Huib N. Caron
Jan Koster

Frontiers in Oncology

doi 10.3389/fonc.2023.1130034

4,410 views
9 citations

Original Research

Published on 16 Feb 2023

Identification and validation of a novel ubiquitination-related gene UBE2T in Ewing’s sarcoma

in Pediatric Oncology

Guoxin Qu
Yuanchun Xu
Ye Qu
Jinchao Qiu
Guosheng Chen
Nannan Zhao
Jin Deng

Frontiers in Oncology

doi 10.3389/fonc.2023.1000949

3,266 views
3 citations

Original Research

Published on 14 Feb 2023

Segmental chromosomal aberrations as the poor prognostic factor in children over 18 months with stage 3 neuroblastoma without MYCN amplification

in Pediatric Oncology

Aleksandra Wieczorek
Katarzyna Szewczyk
Tomasz Klekawka
Joanna Stefanowicz
Marek Ussowicz
Grazyna Drabik
Katarzyna Pawinska-Wasikowska
Walentyna Balwierz

Frontiers in Oncology

doi 10.3389/fonc.2023.1134772

3,882 views
1 citation

Original Research

Published on 13 Feb 2023

A molecular study of pediatric pilomyxoid and pilocytic astrocytomas: Genome-wide copy number screening, retrospective analysis of clinicopathological features and long-term clinical outcome

in Pediatric Oncology

Essam AlShail
Ahmed Nasser Alahmari
Anas A. M. Dababo
Maysoon Alsagob
Hindi Al-Hindi
Hala Khalil
Zainab Al Masseri
Razan AlSalamah
Ethar Almohseny
Amjad Alduhaish

Frontiers in Oncology

doi 10.3389/fonc.2023.1034292

5,730 views
9 citations

Original Research

Published on 07 Feb 2023

Comparison of diagnostic and treatment processes among pediatric and adolescents and young adults’ populations suffering from acute lymphoblastic leukemia and lymphomas

in Pediatric Oncology

Gazala Abdulaziz-Opiela
Anna Sobieraj
Anna Płotka
Barbara Więckowska
Lidia Gil
Katarzyna Derwich

Frontiers in Oncology

doi 10.3389/fonc.2023.1082789

2,619 views
4 citations

Review

Published on 06 Feb 2023

The emerging applications and advancements of Raman spectroscopy in pediatric cancers

in Pediatric Oncology

Chenbei Li
Chengyao Feng
Ruiling Xu
Buchan Jiang
Lan Li
Yu He
Chao Tu
Zhihong Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1044177

3,986 views
4 citations

Original Research

Published on 03 Feb 2023

Dinutuximab beta combined with chemotherapy in patients with relapsed or refractory neuroblastoma

in Pediatric Oncology

Aleksandra Wieczorek
Anna Zaniewska-Tekieli
Karoline Ehlert
Katarzyna Pawinska-Wasikowska
Walentyna Balwierz
Holger Lode

Frontiers in Oncology

doi 10.3389/fonc.2023.1082771

13,120 views
23 citations

Original Research

Published on 30 Jan 2023

Identify potential driver genes for PAX-FOXO1 fusion-negative rhabdomyosarcoma through frequent gene co-expression network mining

in Pediatric Oncology

Xiaohui Zhan
Yusong Liu
Asha Jacob Jannu
Shaoyang Huang
Bo Ye
Wei Wei
Pankita H. Pandya
Xiufen Ye
Karen E. Pollok
Jamie L. Renbarger

Frontiers in Oncology

doi 10.3389/fonc.2023.1080989

3,563 views
1 citation

Original Research

Published on 27 Jan 2023

Epidemiological characteristics, clinical presentations, and prognoses of pediatric brain tumors: Experiences of national center for children’s health

in Pediatric Oncology

Wei Yang
Yingjie Cai
Jiashu Chen
Ping Yang
Zesheng Ying
Yuting Liang
Miao Ling
Kaiyi Zhu
Hailang Sun
Yuanqi Ji

Frontiers in Oncology

doi 10.3389/fonc.2023.1067858

8,242 views
15 citations

Review

Published on 27 Jan 2023

Selective depletion of naïve T cells by targeting CD45RA

in Pediatric Oncology

Swati Naik
Brandon M. Triplett

Frontiers in Oncology

doi 10.3389/fonc.2022.1009143

7,129 views
14 citations

Mini Review

Published on 26 Jan 2023

Addressing blood-brain-tumor-barrier heterogeneity in pediatric brain tumors with innovative preclinical models

in Pediatric Oncology

Elysse K. Morris
Sheena Daignault-Mill
Samantha J. Stehbens
Laura A. Genovesi
Anne K. Lagendijk

Frontiers in Oncology

doi 10.3389/fonc.2023.1101522

6,670 views
23 citations

Editorial

Published on 24 Jan 2023

Editorial: Developmental therapeutics in pediatric neuro-oncology

in Pediatric Oncology

Atsushi Makimoto
Anat Erdreich-Epstein
Yoshihiro Muragaki

Frontiers in Oncology

doi 10.3389/fonc.2023.1134168

1,630 views

Brief Research Report

Published on 18 Jan 2023

Limitations of radiosensitization by direct telomerase inhibition to treat high-risk medulloblastoma

in Pediatric Oncology

Satarupa Sengupta
Shiva Senthil Kumar
Kathryn Bondra
Matthew Sobo
Xiaokui Mo
Rachid Drissi

Frontiers in Oncology

doi 10.3389/fonc.2023.1104670

2,925 views
2 citations

Review

Published on 17 Jan 2023

Clinical utility of nuclear imaging in the evaluation of pediatric adrenal neoplasms

in Pediatric Oncology

Christelle Fargette
Barry Shulkin
Abhishek Jha
Karel Pacak
David Taïeb

Frontiers in Oncology

doi 10.3389/fonc.2022.1081783

3,829 views
8 citations

Brief Research Report

Published on 17 Jan 2023

Prior COVID-19 infection may increase risk for developing endothelial dysfunction following hematopoietic cell transplantation

in Pediatric Oncology

Sydney Ariagno
Dristhi Ragoonanan
Sajad Khazal
Kris M. Mahadeo
Gabriel Salinas Cisneros
Matt S. Zinter
Robyn A. Blacken
Gopi Mohan
Leslie E. Lehmann
Asmaa Ferdjallah

Frontiers in Oncology

doi 10.3389/fonc.2022.1000215

3,064 views
2 citations

665 articles

articles

Case report: First report of isolated central nervous system lymphoblastic crisis in a child with chronic myeloid leukemia on dasatinib therapy

Integrated nontargeted and targeted metabolomics analyses amino acids metabolism in infantile hemangioma

Exploiting embryonic niche conditions to grow Wilms tumor blastema in culture

In vivo loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymoma

Transarterial arterial sclerosing embolization for the treatment of propranolol-resistant subglottic hemangioma: Feasibility and effificacy

Case report: Complete and durable response to larotrectinib (TRK inhibitor) in an infant diagnosed with angiosarcoma harbouring a KHDRBS1-NTRK3 fusion gene

Corrigendum: Murine models of acute myeloid leukemia

Editorial: Critical complications in pediatric oncology and hematopoietic cell transplant – how far we have come and how much further we must go

Haploidentical hematopoietic stem cell transplantation as individual treatment option in pediatric patients with very high-risk sarcomas

MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma

Identification and validation of a novel ubiquitination-related gene UBE2T in Ewing’s sarcoma

Segmental chromosomal aberrations as the poor prognostic factor in children over 18 months with stage 3 neuroblastoma without MYCN amplification

A molecular study of pediatric pilomyxoid and pilocytic astrocytomas: Genome-wide copy number screening, retrospective analysis of clinicopathological features and long-term clinical outcome

Comparison of diagnostic and treatment processes among pediatric and adolescents and young adults’ populations suffering from acute lymphoblastic leukemia and lymphomas

The emerging applications and advancements of Raman spectroscopy in pediatric cancers

Dinutuximab beta combined with chemotherapy in patients with relapsed or refractory neuroblastoma

Identify potential driver genes for PAX-FOXO1 fusion-negative rhabdomyosarcoma through frequent gene co-expression network mining

Epidemiological characteristics, clinical presentations, and prognoses of pediatric brain tumors: Experiences of national center for children’s health

Selective depletion of naïve T cells by targeting CD45RA

Addressing blood-brain-tumor-barrier heterogeneity in pediatric brain tumors with innovative preclinical models

Editorial: Developmental therapeutics in pediatric neuro-oncology

Limitations of radiosensitization by direct telomerase inhibition to treat high-risk medulloblastoma

Clinical utility of nuclear imaging in the evaluation of pediatric adrenal neoplasms

Prior COVID-19 infection may increase risk for developing endothelial dysfunction following hematopoietic cell transplantation